SQSTM1 and sarcopenia: From ~6 to 12 months of age, TSCmKO display a progressive sarcopenia-like phenotype including muscle atrophy and weakness as well as accumulation of p62-labelled proteins and aggregates33, which are also, to some degree, features of sarcopenia13,34.